These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20148716)

  • 1. Galanin receptor subtypes 1 and 2 as therapeutic targets in head and neck squamous cell carcinoma.
    Kanazawa T; Misawa K; Carey TE
    Expert Opin Ther Targets; 2010 Mar; 14(3):289-302. PubMed ID: 20148716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galanin receptor subtype 2 suppresses cell proliferation and induces apoptosis in p53 mutant head and neck cancer cells.
    Kanazawa T; Kommareddi PK; Iwashita T; Kumar B; Misawa K; Misawa Y; Jang I; Nair TS; Iino Y; Carey TE
    Clin Cancer Res; 2009 Apr; 15(7):2222-30. PubMed ID: 19276245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galanin receptor 2 utilizes distinct signaling pathways to suppress cell proliferation and induce apoptosis in HNSCC.
    Kanazawa T; Misawa K; Misawa Y; Maruta M; Uehara T; Kawada K; Nagatomo T; Ichimura K
    Mol Med Rep; 2014 Sep; 10(3):1289-94. PubMed ID: 25017118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel anti-tumor mechanism of galanin receptor type 2 in head and neck squamous cell carcinoma cells.
    Uehara T; Kanazawa T; Mizukami H; Uchibori R; Tsukahara T; Urabe M; Kume A; Misawa K; Carey TE; Suzuki M; Ichimura K; Ozawa K
    Cancer Sci; 2014 Jan; 105(1):72-80. PubMed ID: 24168112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.
    Misawa Y; Misawa K; Kanazawa T; Uehara T; Endo S; Mochizuki D; Yamatodani T; Carey TE; Mineta H
    Cancer; 2014 Jan; 120(2):205-13. PubMed ID: 24122450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer.
    Misawa K; Misawa Y; Kanazawa T; Mochizuki D; Imai A; Endo S; Carey TE; Mineta H
    Clin Exp Metastasis; 2016 Feb; 33(2):187-95. PubMed ID: 26572146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential activation by galanin 1-15 fragment of the GalR1 protomer of a GalR1-GalR2 heteroreceptor complex.
    Borroto-Escuela DO; Narvaez M; Di Palma M; Calvo F; Rodriguez D; Millon C; Carlsson J; Agnati LF; Garriga P; Díaz-Cabiale Z; Fuxe K
    Biochem Biophys Res Commun; 2014 Sep; 452(3):347-53. PubMed ID: 25152404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis.
    Misawa K; Mochizuki D; Endo S; Mima M; Misawa Y; Imai A; Shinmura K; Kanazawa T; Carey TE; Mineta H
    Mol Carcinog; 2017 Mar; 56(3):1107-1116. PubMed ID: 27685843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and differential regulation of galanin receptor subtypes in rat brain: effects of seizure activity.
    Lu X; Mazarati A; Sanna P; Shinmei S; Bartfai T
    Neuropeptides; 2005 Jun; 39(3):147-52. PubMed ID: 15944003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer?
    Kanazawa T; Misawa K; Misawa Y; Uehara T; Fukushima H; Kusaka G; Maruta M; Carey TE
    Toxins (Basel); 2015 Aug; 7(8):2959-84. PubMed ID: 26251921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes.
    Wang S; Hashemi T; Fried S; Clemmons AL; Hawes BE
    Biochemistry; 1998 May; 37(19):6711-7. PubMed ID: 9578554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galanin receptor 1 has anti-proliferative effects in oral squamous cell carcinoma.
    Henson BS; Neubig RR; Jang I; Ogawa T; Zhang Z; Carey TE; D'Silva NJ
    J Biol Chem; 2005 Jun; 280(24):22564-71. PubMed ID: 15767248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of galanin receptor 1 and galanin receptor 2 activation in synaptic plasticity associated with 3',5'-cyclic AMP response element-binding protein phosphorylation in the dentate gyrus: studies with a galanin receptor 2 agonist and galanin receptor 1 knockout mice.
    Badie-Mahdavi H; Lu X; Behrens MM; Bartfai T
    Neuroscience; 2005; 133(2):591-604. PubMed ID: 15885916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of galanin receptors 1 and 2 in the modulation of mouse vagal afferent mechanosensitivity.
    Page AJ; Slattery JA; Brierley SM; Jacoby AS; Blackshaw LA
    J Physiol; 2007 Sep; 583(Pt 2):675-84. PubMed ID: 17627995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galanin receptor subtype GalR2 mediates apoptosis in SH-SY5Y neuroblastoma cells.
    Berger A; Lang R; Moritz K; Santic R; Hermann A; Sperl W; Kofler B
    Endocrinology; 2004 Feb; 145(2):500-7. PubMed ID: 14592962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordinated Targeting of Galanin Receptors on Cholangiocytes and Hepatic Stellate Cells Ameliorates Liver Fibrosis in Multidrug Resistance Protein 2 Knockout Mice.
    Petrescu AD; Grant S; Williams E; Frampton G; Parks N; Blaney H; Davies M; John R; Reinhart EH; McMillin M; DeMorrow S
    Am J Pathol; 2020 Mar; 190(3):586-601. PubMed ID: 31953035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive and ligand-induced internalization of EGFP-tagged galanin R2 and Rl receptors in PC12 cells.
    Xia S; Kjaer S; Zheng K; Hu PS; Xu T; Hökfelt T; Xu ZQ
    Neuropeptides; 2005 Jun; 39(3):173-8. PubMed ID: 15885774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of GalR1, GalR2, and GalR3 immunoreactivity in catecholaminergic nuclei of the mouse brain.
    Hawes JJ; Picciotto MR
    J Comp Neurol; 2004 Nov; 479(4):410-23. PubMed ID: 15514977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GalR1, but not GalR2 or GalR3, levels are regulated by galanin signaling in the locus coeruleus through a cyclic AMP-dependent mechanism.
    Hawes JJ; Brunzell DH; Wynick D; Zachariou V; Picciotto MR
    J Neurochem; 2005 Jun; 93(5):1168-76. PubMed ID: 15934937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of limbic status epilepticus by hippocampal galanin type 1 and type 2 receptors.
    Mazarati A; Lu X
    Neuropeptides; 2005 Jun; 39(3):277-80. PubMed ID: 15944022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.